NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis
Advanced SearchBrowse by AnalyteBrowse by Pre-analytical FactorSearch SOPsSOP Compendiums

PAI-1 ELISA   Add to my SOP compendium

BRD ID: 2,029

Source: TCP Project Tier: SOP Number of times downloaded: 486

Description

This document describes the protocol used by the Pathology and Laboratory Medicine Department of Boston Medical Center (BMC) to quantify levels of plasminogen activator inhibitor-1 (PAI-1) in plasma by ELISA as part of the Thrombosis in Cancer Patients (TCP) Project. It is a product of the Center for Strategic Scientific Initiatives (CSSI) of the National Institutes of Health (NIH) (https://cssi.cancer.gov/cancer-thrombosis).

Documents for Download

BARC PRO 020 Plasminogen Activator Inhibitor-1 antigen (PAI-1Ag).pdf [Size: 4950 KB]
Biospecimens
  • Fluid - Plasma
Diagnoses
  • Normal
  • Neoplastic - Carcinoma
Topics
  • Biospecimen Processing
  • Platform-specific Methodology

Associated SOP Compendiums

News and Announcements

  • New Articles on the GTEx Project are Now FREELY Available!
  • Just Published!
  • April 24, 2024: Biobanking for Precision Medicine Seminar
    • More...